PharmaKodex Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $11.3M

PharmaKodex General Information

Description

Developer of small molecule drugs for treating pain and neurological conditions.

Contact Information

Website
www.pharmakodex.com
Formerly Known As
Newincco 405 Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1 Prospect West
  • Chippenham SN14 6FH
  • England, United Kingdom
+44 01249
Primary Industry
Drug Discovery
Acquirer
Orexo
Corporate Office
  • 1 Prospect West
  • Chippenham SN14 6FH
  • England, United Kingdom
+44 01249

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaKodex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Aug-2009 $11.3M Completed Product Development
1. Early Stage VC (Series A) 16-Nov-2006 Completed Product Development
To view PharmaKodex’s complete valuation and funding history, request access »

PharmaKodex Patents

  • 96

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • Pending

  • Expiring in next 12 mo

PharmaKodex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0910559-D0 Packaging receptacle Inactive 19-Jun-2009
GB-0910560-D0 Packaging receptacle Inactive 19-Jun-2009
GB-0823486-D0 Formulations Inactive 24-Dec-2008
GB-0823493-D0 Formulations Inactive 24-Dec-2008
GB-0819981-D0 Packaging receptacle Inactive 31-Oct-2008
To view PharmaKodex’s complete patent history, request access »

PharmaKodex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaKodex Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apposite Capital PE/Buyout Minority
SR One Corporate Venture Capital Minority
Unilever Ventures Corporate Venture Capital Minority
Vectura Group Corporation Minority
To view PharmaKodex’s complete investors history, request access »

Ready to get started?

Request a free trial

PharmaKodex FAQs

  • When was PharmaKodex founded?

    PharmaKodex was founded in 2005.

  • Where is PharmaKodex headquartered?

    PharmaKodex is headquartered in Chippenham, United Kingdom.

  • What is the size of PharmaKodex?

    PharmaKodex has 2 total employees.

  • What industry is PharmaKodex in?

    PharmaKodex’s primary industry is Drug Discovery.

  • Is PharmaKodex a private or public company?

    PharmaKodex is a Private company.

  • What is the current valuation of PharmaKodex?

    The current valuation of PharmaKodex is .

  • What is PharmaKodex’s current revenue?

    The current revenue for PharmaKodex is .

  • How much funding has PharmaKodex raised over time?

    PharmaKodex has raised $13.5M.

  • Who are PharmaKodex’s investors?

    Apposite Capital, SR One, Unilever Ventures, and Vectura Group have invested in PharmaKodex.

  • When was PharmaKodex acquired?

    PharmaKodex was acquired on 21-Aug-2009.

  • Who acquired PharmaKodex?

    PharmaKodex was acquired by Orexo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process